FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387380212> ?p ?o ?g. }

• W4387380212 abstract "Abstract Disclosure: A. Etella: None. T. Scully: None. S. Jordan: None. C. Kang: None. M.G. Jeffrey: None. N.G. Kase: None. D. LeRoith: None. E.J. Gallagher: Advisory Board Member; Self; Novartis Pharmaceuticals. Consulting Fee; Self; Seagen, Flare Therapeutics. Excess body weight and dyslipdemia have been associated with reduced disease-free, and overall survival in women with triple negative breast cancer (TNBC). TNBC does not express hormone (estrogen or progesterone) receptors, or overexpress human epidermal growth factor receptor (HER2) and accounts for 10-20% of breast cancers globally, although amongst some populations (e.g. Black women in the US) the rates are higher. The mechanisms linking dyslipidemia and TNBC outcomes are not well understood. To study the mechanisms involved, we injected murine (Mvt1) or human (MDA-MB-231) TNBC cells into the inguinal fat pad of immunocompetent or immunodeficient dyslipidemic apolipoprotein E knockout (ApoE-/-) mice and respective controls. Tumors grew larger and developed more metastasis in the ApoE-/- mice compared with controls. We examined the oxysterol content of the tumors and found higher concentrations of 25-hydroxycholesterol (25-OHC) in the Mvt1 tumors from ApoE-/- mice compared with controls (2.05±0.8ng/mg vs 0.33±0.09ng/mg, P=0.048, n=6 per group). Similarly concentrations were higher in the MDA-MB-231 tumors from immunocompromised ApoE-/- mice compared with controls (0.06±0.007ng/mg vs 0.002±0.004ng/mg, P=0.008, n=6 per group). To explore the importance of 25-OHC in TNBC growth and metastasis, we used the cholesterol 25 hydroxylase knockout (Ch25h-/-) mice on the C57BL/6 background and backcrossed the mice to the FVB/n background. In the C57BL/6 Ch25h-/- and control mice, we injected M-Wnt cells into the inguinal fat pad. We found no difference in primary tumor growth, but significantly fewer metastases (mets) in the lungs in the Ch25h-/- mice compared with controls (1.7±1.1 vs 15.3±6.7 mets/mouse, P&lt;0.01). Similarly no difference in primary tumor size was observed between groups in the FVB/n mice, but the Ch25h-/- mice again had fewer lung metastases compared with controls (6.0±0.9 vs 14.5±2.1 mets/mouse, P&lt;0.01, n=8-9 per group). The M-Wnt and Mvt1tumor cells did not express significant levels of Ch25h; however, high levels of CH25H have been observed in macrophages in the breast. In vitro, we found that 25-OHC stimulation of macrophages induced the secretion chemokines IL8, CCL3, CCL4, and increased the migration of human MDA-MB-231 and MDA-MB-468 breast cancer cells. The expression of these chemokines was found to be &gt;50% lower in the M-Wnt and Mvt1 tumors from the Ch25h-/- mice compared with controls. These results show that the 25-OHC in the tumor microenvironment plays an important role in TNBC metastasis and may be an important mechanism linking dyslipidemia with poor TNBC survival. Presentation: Friday, June 16, 2023" @default.
• W4387380212 created "2023-10-06" @default.
• W4387380212 creator A5008530358 @default.
• W4387380212 creator A5010271421 @default.
• W4387380212 creator A5025273947 @default.
• W4387380212 creator A5030291239 @default.
• W4387380212 creator A5048413470 @default.
• W4387380212 creator A5053675595 @default.
• W4387380212 creator A5056448079 @default.
• W4387380212 creator A5093011356 @default.
• W4387380212 date "2023-10-01" @default.
• W4387380212 modified "2023-10-16" @default.
• W4387380212 title "OR16-05 25-Hydroxycholesterol Mediates The Effects Of Dyslipidemia On Triple Negative Breast Cancer Metastasis" @default.
• W4387380212 doi "https://doi.org/10.1210/jendso/bvad114.2197" @default.
• W4387380212 hasPublicationYear "2023" @default.
• W4387380212 type Work @default.
• W4387380212 citedByCount "0" @default.
• W4387380212 crossrefType "journal-article" @default.
• W4387380212 hasAuthorship W4387380212A5008530358 @default.
• W4387380212 hasAuthorship W4387380212A5010271421 @default.
• W4387380212 hasAuthorship W4387380212A5025273947 @default.
• W4387380212 hasAuthorship W4387380212A5030291239 @default.
• W4387380212 hasAuthorship W4387380212A5048413470 @default.
• W4387380212 hasAuthorship W4387380212A5053675595 @default.
• W4387380212 hasAuthorship W4387380212A5056448079 @default.
• W4387380212 hasAuthorship W4387380212A5093011356 @default.
• W4387380212 hasBestOaLocation W43873802121 @default.
• W4387380212 hasConcept C121608353 @default.
• W4387380212 hasConcept C126322002 @default.
• W4387380212 hasConcept C134018914 @default.
• W4387380212 hasConcept C143998085 @default.
• W4387380212 hasConcept C2778096610 @default.
• W4387380212 hasConcept C2778163477 @default.
• W4387380212 hasConcept C2779013556 @default.
• W4387380212 hasConcept C2779134260 @default.
• W4387380212 hasConcept C2780110267 @default.
• W4387380212 hasConcept C502942594 @default.
• W4387380212 hasConcept C530470458 @default.
• W4387380212 hasConcept C57089818 @default.
• W4387380212 hasConcept C62746215 @default.
• W4387380212 hasConcept C71924100 @default.
• W4387380212 hasConcept C84606932 @default.
• W4387380212 hasConceptScore W4387380212C121608353 @default.
• W4387380212 hasConceptScore W4387380212C126322002 @default.
• W4387380212 hasConceptScore W4387380212C134018914 @default.
• W4387380212 hasConceptScore W4387380212C143998085 @default.
• W4387380212 hasConceptScore W4387380212C2778096610 @default.
• W4387380212 hasConceptScore W4387380212C2778163477 @default.
• W4387380212 hasConceptScore W4387380212C2779013556 @default.
• W4387380212 hasConceptScore W4387380212C2779134260 @default.
• W4387380212 hasConceptScore W4387380212C2780110267 @default.
• W4387380212 hasConceptScore W4387380212C502942594 @default.
• W4387380212 hasConceptScore W4387380212C530470458 @default.
• W4387380212 hasConceptScore W4387380212C57089818 @default.
• W4387380212 hasConceptScore W4387380212C62746215 @default.
• W4387380212 hasConceptScore W4387380212C71924100 @default.
• W4387380212 hasConceptScore W4387380212C84606932 @default.
• W4387380212 hasIssue "Supplement_1" @default.
• W4387380212 hasLocation W43873802121 @default.
• W4387380212 hasOpenAccess W4387380212 @default.
• W4387380212 hasPrimaryLocation W43873802121 @default.
• W4387380212 hasRelatedWork W1572905580 @default.
• W4387380212 hasRelatedWork W166747667 @default.
• W4387380212 hasRelatedWork W1988062963 @default.
• W4387380212 hasRelatedWork W2039412011 @default.
• W4387380212 hasRelatedWork W2366041794 @default.
• W4387380212 hasRelatedWork W2372035975 @default.
• W4387380212 hasRelatedWork W2393378262 @default.
• W4387380212 hasRelatedWork W2987751125 @default.
• W4387380212 hasRelatedWork W3214989315 @default.
• W4387380212 hasRelatedWork W4378213864 @default.
• W4387380212 hasVolume "7" @default.
• W4387380212 isParatext "false" @default.
• W4387380212 isRetracted "false" @default.
• W4387380212 workType "article" @default.